Sexually Transmitted Diseases

At the Centers for Disease Control and Prevention's 2016 STD Prevention Conference, researchers discussed three novel prevention strategies for HIV, other STIs, and unintended pregnancies.

The monoclonal antibody, ibalizumab, has proven to be both safe and effective in treating patients who are infected with multi-drug-resistant HIV-1 and have been previously treated.

“The number of people who experience the devastating effects of preventable infectious diseases like measles, diphtheria, and whooping cough is at an all-time low," according to the Centers for Disease Control and Prevention (CDC).

At the annual meeting of the Infectious Diseases Society of America in New Orleans, Louisiana, Judith Currier, MD, from the University of California, Los Angeles, discussed the many challenges that HIV-positive individuals face as they live longer lives.

Speakers at the Infectious Diseases Society of America annual conference plenary symposium in New Orleans, Louisiana, discuss past successes, current challenges, and future efforts regarding infectious disease.

Thirty years after the 1980s AIDS crisis, researchers have proven that Gaétan Dugas, known as Patient Zero, was, in fact, not the first AIDS case.

Researchers from Sweden’s Linköping University discover the pathway that leads to deadly infections in people co-infected with HIV and TB.

During the 2016 HIV Research and Prevention (HIVR4P) meeting in Chicago, researchers conducting trials to assess the safety and efficacy of the dapivirine vaginal ring announced several key findings and insights of the ASPIRE study, known as MTN-020.

The Centers for Disease Control and Prevention reported a rise in STDs and a dent in preventive services in their 2015 Sexually Transmitted Disease Surveillance report.

Changes in strain prevalence indicate that the existing 9-valent HPV vaccines may offer some protection against an additional high-risk strain that is not included in the vaccine (strain 31), potentially due to antigenic similarities with other strains.

Stephen Redd, MD (RADM, USPHS), Director of the Office of Public Health Preparedness and Response (OPHPR) at the Centers for Disease Control and Prevention (CDC), discusses Zika and sexual transmission.

The new Centers for Disease Control and Prevention (CDC) recommendations call for a revised dosing schedule.

Technology gives men who have sex with men (MSM) new ways to assess their health status, prevent HIV and other STDs (sexually transmitted diseases), and find care.

Older Americans who are sexually active are not being tested for HIV and are not being educated about how to prevent disease transmission, new research suggests.

New prevention and treatment models are needed worldwide and one such model is the Dean Street Express Clinic in London, England.

In a recent study, researchers investigated the treatment and prevention of HIV within trauma-informed care.

A team of researchers at the University of California has found that veterans infected with both hepatitis C and human immunodeficiency virus sought treatment more often than those infected with just one of the viruses.

In the 10 years since the human papilloma virus (HPV) vaccine first became available, a series of new studies have come out showing just how effective the virus really is and how HPV vaccination rates can be improved in adolescents.

Over-the-counter diagnostic tests for Chlamydia trachomatis, Neisseria gonorrhoeae, and pathogens associated with upper respiratory tract infections such as influenza and Group A Streptococcus may soon gain approval; however, making these tests immediately available to the public would not be without challenges.

Gonorrhea may soon become untreatable with current antibiotics, according to recent research presented at the Centers for Disease Control and Prevention's 2016 STD Prevention Conference.

A 44-year-old man from Britain could become the first patient ever to be cured of HIV, thanks to a groundbreaking new therapy developed to eradicate the virus.

The National Institutes of Health (NIH) has provided funding of $24 million this year to the Adolescent Medicine Trials Network for HIV/AIDS Interventions, the first clinical research group that will focus on youth infected by HIV.

Researchers at the University of Zurich and the University Hospital-Zurich have made a discovery that may contribute to the development of an effective HIV vaccine.

Kenneth Fife, MD, PhD, Professor of Medicine at Indiana University, School of Medicine, discusses whether or not his genital herpes vaccine, GEN-003, can protect against oral herpes.